![Kerstin A. David](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kerstin A. David
Chief Tech/Sci/R&D Officer at Indivumed GmbH
Profile
Kerstin A.
David is currently the Chief Scientific Officer at Indivumed GmbH.
Prior to this, she worked as an Assistant Professor at the University of Hamburg and the Cancer Research Center of Hawaii.
She holds a doctorate degree from the University of Hamburg.
Kerstin A. David active positions
Companies | Position | Start |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Chief Tech/Sci/R&D Officer | 2001-12-31 |
Former positions of Kerstin A. David
Companies | Position | End |
---|---|---|
Cancer Research Center of Hawaii | Corporate Officer/Principal | - |
University of Hamburg | Corporate Officer/Principal | - |
Training of Kerstin A. David
University of Hamburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
Cancer Research Center of Hawaii |
- Stock Market
- Insiders
- Kerstin A. David